Evidence map›Paper›PMID 33925273›Full record

ArticleInternational journal of molecular sciences2021

Molecular Characterization of Xyloglucanase

Douglas Christian Borges Lopes, Cláudia Batista Carraro, Roberto Nascimento Silva, Renato Graciano de Paula

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Douglas Christian Borges LopesMolecular Biotechnology Laboratory, Department of Biochemistry and Immunology, Ribeirao Preto Medical School (FMRP), University of Sao Paulo, Ribeirao Preto 14049-900, SP, Brazil.ORCID 0000-0002-9747-0302
Cláudia Batista CarraroMolecular Biotechnology Laboratory, Department of Biochemistry and Immunology, Ribeirao Preto Medical School (FMRP), University of Sao Paulo, Ribeirao Preto 14049-900, SP, Brazil.
Roberto Nascimento SilvaMolecular Biotechnology Laboratory, Department of Biochemistry and Immunology, Ribeirao Preto Medical School (FMRP), University of Sao Paulo, Ribeirao Preto 14049-900, SP, Brazil.
Renato Graciano de PaulaMolecular Biotechnology Laboratory, Department of Biochemistry and Immunology, Ribeirao Preto Medical School (FMRP), University of Sao Paulo, Ribeirao Preto 14049-900, SP, Brazil.ORCID 0000-0002-6712-437X
Universidade de São Paulo · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 301921/2018-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/09708-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/23233-9
6 · The paper itself

Abstract

backgroundThe filamentous fungus

methodsHere, we constructed a null mutant strain for the xyloglucanase

resultsOur results demonstrate that the deletion of xyloglucanase

conclusionsCEL74A affects the regulation of holocellulolytic genes and the efficient degradation of SCB in

Indexed as

BiomassCellulasesCelluloseFungal ProteinsGlycoside HydrolasesHydrolysisHypocrealesSaccharumTrichodermabagasseCellulasesCelluloseFungal ProteinsGlycoside Hydrolaseshemicellulasexyloglucan endo(1-4)-beta-D-glucanaseholocellulasesugarcane bagasse (SCB)Trichoderma reeseixyloglucanasexyloglucan breakdown

Identifiers

PMID33925273
PMCPMC8123685
OpenAlexW3158032231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.